Truxima Interactions
There are 192 drugs known to interact with Truxima (rituximab), along with 7 disease interactions. Of the total drug interactions, 53 are major, 134 are moderate, and 5 are minor.
- View all 192 medications that may interact with Truxima
- View Truxima disease interactions (7)
Most frequently checked interactions
View interaction reports for Truxima (rituximab) and the medicines listed below.
- Actemra (tocilizumab)
- albuterol
- amlodipine
- amoxicillin / clavulanate
- atorvastatin
- baclofen
- Benadryl (diphenhydramine)
- benzonatate
- bupropion
- doxycycline
- famotidine
- folic acid
- gabapentin
- hydroxychloroquine
- ibuprofen
- levothyroxine
- losartan
- melatonin
- meloxicam
- methotrexate
- montelukast
- mycophenolate mofetil
- omeprazole
- ondansetron
- pantoprazole
- prednisone
- sertraline
- tramadol
- trazodone
- Vitamin D3 (cholecalciferol)
Truxima disease interactions
There are 7 disease interactions with Truxima (rituximab) which include:
- autoimmune diseases
- cardiac dysfunction
- hepatitis B
- TLS
- bone marrow suppression
- infections
- renal impairment
More about Truxima (rituximab)
- Truxima consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Monjuvi
Monjuvi (tafasitamab-cxix) is used for the treatment of relapsed or refractory diffuse large B-cell ...
Kymriah
Kymriah is used to treat acute lymphoblastic leukemia (ALL) that is relapsing or refractory in ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma, two types of non-Hodgkin ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Lunsumio
Lunsumio (mosunetuzumab-axgb) is used for the treatment of relapsed or refractory follicular ...
Columvi
Columvi is used to treat certain types of diffuse large B-cell lymphoma (DLBCL) or large B-cell ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.